Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186663 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetics of Advantage Arrest in Children
A Phase 2 study, sponsored by Advantage Silver Dental Arrest.
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT04186663 is a Phase 2 study that has completed, run by Advantage Silver Dental Arrest. The registered enrollment target is 59 participants.
The verdict
NCT04186663, a Phase 2 study, has completed, sponsored by Advantage Silver Dental Arrest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize basic PK parameters (Cmax, t1/2, AUC) in healthy children to contribute to evidence for the safety of Advantage Arrest, consistent with Guidance for Industry--Exposure--Response Relationships (April 2003).
Interventions
- DRUG Silver Diamine Fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2020-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04186663
The ClinicalTrials.gov registry entry for NCT04186663 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advantage Silver Dental Arrest, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Silver Diamine Fluoride is the first listed.
NCT04186663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04186663 about?
NCT04186663 is a clinical study titled "Pharmacokinetics of Advantage Arrest in Children". The purpose of this study is to characterize basic PK parameters (Cmax, t1/2, AUC) in healthy children to contribute to evidence for the safety of Advantage Arrest, consistent with Guidance for Industry--Exposure--Response Relationships (April 2003).
What is the current status of trial NCT04186663?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2019-08-01. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT04186663?
The interventions under investigation include: Silver Diamine Fluoride (DRUG).
Who is sponsoring clinical trial NCT04186663?
This trial is sponsored by Advantage Silver Dental Arrest, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.